Clinical, Morphologic, and Genomic Differences in Deep-Penetrating Nevi and Deep-Penetrating Nevus-like Melanomas
Modern Pathology · 2025
DOI: 10.1016/j.modpat.2025.100707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2025. Verfasst von Lu Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Nevus, Pigmented, Biomarkers, Tumor. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: IDP Foundation.
Abstract (Originalsprache)
Deep-penetrating nevi (DPNs) are characterized by activating mutations in the MAP kinase and Wnt/β-catenin pathways that result in large melanocytes with increased nuclear atypia, cytoplasmic pigmentation, and often mitotic activity. Together with a lack of maturation, this constellation of findings creates challenges for pathologists to distinguish DPN from DPN-like melanoma. To assess the utility of next-generation sequencing (NGS) in resolving this diagnostic dilemma, we performed NGS studies on 35 lesions including 24 DPNs and 11 DPN-like melanomas to characterize the specific genomic differences between the 2 groups and elucidate the genetic events involved in malignant transformation of DPNs. Compared with DPNs, DPN-like melanomas were clinically larger in size (1.1 vs 0.6 cm, P = .02) and on histopathologic examination more frequently showed high-grade nuclear atypia (11/11 vs 9/24; P = .00052), increased mitotic activity (mean 3.9 vs 1.3 per mm2; P = .0004), sheet-like growth pattern (5/11 vs 2/24; P = .01), and involvement of the subcutis (4/5 vs 3/13; P = .026). From a genomic standpoint, DPN-like melanomas had a higher tumor mutation burden (mean 37.1 vs 7.8 mutations/megabase; P = .002) than DPNs and more frequently harbored NRAS mutation (3/11 vs 1/24; P = .046), whereas MAP2K1 in-frame deletions were only identified in DPNs (0/11 vs 5/24). There was no statistically significant difference in the frequency or type of CTNNB1 or APC mutations between the 2 groups. Within progression genes, DPN-like melanomas were more frequently found to have pathogenic variants in TERT promoter (7/11 vs 0/24; P < .00001), CDKN2A (4/11 vs 0/24; P = .0008), and protein subunits of the SWI/SNF complex (7/11 vs 3/24; P = .02) compared with DPNs. Our findings provide a framework for employing NGS in the evaluation of deep-penetrating melanocytic tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
- Department of Molecular Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
- Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois. Electronic address: pedram.gerami@nm.org.
Förderung
- IDP Foundation
Zitieren
APA
Chen, L., Chen, A., Sharma, N., Patel, P., Addo, A. K., Jeyakumar, J. E., Beydoun, H. M., Olivares, S., Dittmann, D., Vormittag-Nocito, E., Dos Santos, L. S., Jennings, L., & Gerami, P. (2025). Clinical, Morphologic, and Genomic Differences in Deep-Penetrating Nevi and Deep-Penetrating Nevus-like Melanomas. Modern Pathology. https://doi.org/10.1016/j.modpat.2025.100707
Vancouver
Chen L, Chen A, Sharma N, Patel P, Addo AK, Jeyakumar JE, et al. Clinical, Morphologic, and Genomic Differences in Deep-Penetrating Nevi and Deep-Penetrating Nevus-like Melanomas. Modern Pathology. 2025. doi:10.1016/j.modpat.2025.100707
BibTeX
@article{Chen2025,
author = {Chen, Lu and Chen, Alice and Sharma, Natasha and Patel, Pragi and Addo, Afua Konadu and Jeyakumar, Julia Edwin and Beydoun, Haya Mary and Olivares, Shantel and Dittmann, David and Vormittag-Nocito, Erica and Dos Santos, Lucas Santana and Jennings, Lawrence and Gerami, Pedram},
title = {Clinical, Morphologic, and Genomic Differences in Deep-Penetrating Nevi and Deep-Penetrating Nevus-like Melanomas},
journal = {Modern Pathology},
year = {2025},
doi = {10.1016/j.modpat.2025.100707}
}
EUVIMED